SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 424B3 - Prospectus [Rule 424(b)(3)]:
SEC Accession No. 0001628280-24-013644
Filing Date
2024-03-28
Accepted
2024-03-28 16:45:04
Documents
21

Document Format Files

Seq Description Document Type Size
1 424B3 gri-424b3prosuppno5todec20a.htm 424B3 2088958
2 business10aa.jpg GRAPHIC 44408
3 business11aa.jpg GRAPHIC 34482
4 business12aa.jpg GRAPHIC 53120
5 business13aa.jpg GRAPHIC 395414
6 business14aa.jpg GRAPHIC 57447
7 business15aa.jpg GRAPHIC 15021
8 business16aa.jpg GRAPHIC 19551
9 business1aa.jpg GRAPHIC 44628
10 business2aa.jpg GRAPHIC 37056
11 business3aa.jpg GRAPHIC 52730
12 business4aa.jpg GRAPHIC 23524
13 business5aa.jpg GRAPHIC 39590
14 business6aa.jpg GRAPHIC 83695
15 business7aa.jpg GRAPHIC 43990
16 business8aa.jpg GRAPHIC 31742
17 business9aa.jpg GRAPHIC 39199
18 grilogo.jpg GRAPHIC 111872
19 image_0a.jpg GRAPHIC 7155
20 image_1a.jpg GRAPHIC 9557
21 image_2a.jpg GRAPHIC 2343
  Complete submission text file 0001628280-24-013644.txt   3667534
Mailing Address 2223 AVENIDA DE LA PLAYA SUITE 208 LA JOLLA CA 92037
Business Address 2223 AVENIDA DE LA PLAYA SUITE 208 LA JOLLA CA 92037 (619) 400-1171
GRI BIO, Inc. (Filer) CIK: 0001824293 (see all company filings)

IRS No.: 824369909 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 424B3 | Act: 33 | File No.: 333-274972 | Film No.: 24799876
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)